Hangzhou Leap Chem Co., Ltd. is one of the most professional manufacturers and suppliers of afoxolaner丨cas 1093861-60-9 in China. Welcome to wholesale bulk high quality chemical products at competitive price from our factory. If you have any enquiry about custom service, please feel free to email us.
Specifications of Afoxolaner丨CAS 1093861-60-9
|
Appearance: |
White or off-white powder |
|
Assay: |
98% - 102.0% |
|
Solubility: |
Slightly soluble in DMSO |
|
Identification: |
HPLC (The retention time of sample is consistent with that of reference standard) |
|
Individual impurity: |
0.3% max |
|
Total impurities: |
1.0% max |
|
Water: |
1.0% max |
|
Residue on ignition: |
0.1% max |
|
Heavy metal: |
10 ppm max |
Transport Information of Afoxolaner丨CAS 1093861-60-9
|
Parameter |
Specification |
|
UN Number |
|
|
Class |
|
|
Packing Group |
|
|
H.S. Code |
2922299090306 |
|
Stability & Reactivity |
The product is chemically stable under standard ambient conditions. |
|
Storage |
Store at -20°C |
|
Condition to Avoid |
|
|
Package |
Manufacturing Information of Afoxolaner丨CAS 1093861-60-9
|
Parameter |
Specification |
|
Capacity |
|
|
Frequency |
|
|
Main Export Countries |
|
|
Capacity/Batch |
|
|
Experience |
Production since 2015 |
|
Stock |
Small quantity in stock |
Overview
Afoxolaner丨CAS 1093861-60-9 is a systemic insecticide and acaricide widely used in veterinary medicine to control fleas and ticks in companion animals such as dogs and cats.
Applications
1. Veterinary Medicine
Flea and Tick Control:
Afoxolaner丨CAS 1093861-60-9 is the active ingredient in several commercial oral formulations (e.g., NexGard®) used for the treatment and prevention of flea and tick infestations in dogs. It provides rapid and long-lasting protection.
Broad-Spectrum Ectoparasite Control:
Effective against multiple tick species (including Ixodes, Dermacentor, and Rhipicephalus), fleas (Ctenocephalides felis), and some mites, making it valuable for comprehensive parasite control.
2. Animal Health and Welfare
Prevention of Vector-Borne Diseases:
By controlling ticks and fleas, Afoxolaner helps reduce the transmission risk of diseases such as Lyme disease, ehrlichiosis, and flea allergy dermatitis in pets.
Convenience and Compliance:
Oral administration with monthly dosing improves owner compliance compared to topical treatments.
Mode of Action
Afoxolaner acts as a potent antagonist of insect and acarid γ-aminobutyric acid (GABA)-gated chloride channels and glutamate-gated chloride channels, causing uncontrolled nervous system activity in parasites, leading to paralysis and death.
It selectively targets parasites with minimal effects on mammals due to differences in receptor structure.
Benefits
1. High Efficacy
Rapid onset of action, killing fleas within hours and ticks within a day.
Provides long-lasting protection (up to one month).
2. Safety Profile
Well tolerated by dogs and cats at recommended doses.
Minimal adverse effects reported in clinical use.
3. Convenience
Oral chewable tablets are easy to administer, improving treatment adherence.
No need for topical application or collars.
4. Reduced Parasite Resistance
Isoxazoline class offers a new mode of action distinct from older ectoparasiticides, helping to manage resistance issues.
Conclusion
Afoxolaner丨CAS 1093861-60-9 is a highly effective and widely used oral insecticide and acaricide in veterinary medicine. Its broad-spectrum activity against fleas and ticks, excellent safety profile, and convenient oral administration make it a leading choice for protecting companion animals from ectoparasites and related diseases.

